Long term functional outcome and quality of life of patients with refractory juvenile idiopathic arthritis treated with etanercept: results of the dutch arthritis and biologicals in children register

Lignende værker

• Etanercept in juvenile idiopathic arthritis: Who will benefit?
  af: van den Berg JM, et al.
  Udgivet: (2011-09-01)
• Etanercept in juvenile idiopathic arthritis: Who will benefit?
  af: Otten, MH, et al.
  Udgivet: (2011)
• When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis
  af: Prince, FHM, et al.
  Udgivet: (2008)
• PReS-FINAL-2146: Trends in prescription of biologics and outcomes of juvenile idiopathic arthritis; results of the Dutch national arthritis and biologicals in children register
  af: Otten, MH, et al.
  Udgivet: (2013)
• PReS-FINAL-2145: MRP8/14 serum complexes as predictor of response to etanercept treatment in juvenile idiopathic arthritis
  af: Anink, J, et al.
  Udgivet: (2013)